RPM for Oncology: Data Collection

Remote patient monitoring (RPM) is a key component of digital health, especially in the field of oncology. Its applications in improving patient outcomes, reducing healthcare costs, and enhancing clinical trials are well-documented and growing. But how can the pharmaceutical industry engage with this evolving field to deliver substantive value to end users?

Register for this roundtable discussion focused on identifying where and how pharma can leverage RPM technology. We will discuss: 

• How can pharma assess their suitability as partners for oncology RPM initiatives?

• What role does RPM play in oncology, and how can pharma enhance value through data collection, integration, and analysis?

• What is the optimal approach for pharma when it comes to remote monitoring in oncology - integration, partnering with health tech companies, or collaborating with established EMR providers?

• Should pharma launch standalone RPM solutions, act as data aggregators, or pursue other models to maximise impact?

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high-quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.